Why is Health.Global falling/rising?

As of 24-Sep, Healthcare Global Enterprises Ltd is experiencing a decline in its stock price, currently at 649.70, reflecting a decrease of 9.45 points or 1.43%. The stock has underperformed its sector by 0.81% today and has shown a trend reversal after two consecutive days of gains. Despite a strong year-to-date return of 33.08% and a remarkable 54.62% increase over the past year, the stock has faced challenges, including a recent drop of 3.27% over the past week. The company's return on capital employed (ROCE) stands at 7.3, indicating an attractive valuation, but its profits have fallen by 24.9%, which raises concerns about its long-term fundamental strength. Additionally, 88% of promoter shares are pledged, which can exert downward pressure on the stock in a declining market.
In the broader market context, the stock's short-term performance has been weaker compared to the benchmark, with a 1-week decline of 3.27% against the Sensex's drop of 1.18%. While the stock has outperformed the BSE500 over the long term, the recent negative results, including a significant drop in profit after tax and a high debt-to-EBITDA ratio of 3.91 times, contribute to a cautious outlook. The increase in pledged shares by 83.01% over the last quarter further complicates the situation, as it may signal reduced confidence among promoters and investors alike.